Evaluating integrated supportive care pathways for cancer patients
Integrating PROACTive Care Pathways to Empower and Support Cancer Patients (PROACT)
Gustave Roussy, Cancer Campus, Grand Paris · NCT06479057
This study is testing a new supportive care program for cancer patients to see if it helps reduce their distress and improve their overall well-being over 12 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Gustave Roussy, Cancer Campus, Grand Paris (other) |
| Locations | 1 site (Villejuif) |
| Trial ID | NCT06479057 on ClinicalTrials.gov |
What this trial studies
PROACT is an observational cohort study designed to assess the implementation of integrated proactive supportive care pathways for cancer patients. The study focuses on measuring patient distress and supportive care needs using the NCCN Distress Thermometer over a 12-week period following an assessment. Secondary endpoints include evaluating the reach and diversity of the pathways, as well as their impact on overall health status, quality of life, symptom burden, anxiety, insomnia, and sexual health. The study aims to enhance the quality of care provided to cancer patients through structured supportive interventions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with any histologically confirmed cancer who can provide informed consent and have received a supportive care needs assessment.
Not a fit: Patients who cannot provide written consent or do not understand or speak French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce patient distress and improve overall quality of life for cancer patients.
How similar studies have performed: Other studies have shown success in implementing supportive care pathways for cancer patients, indicating that this approach is promising and not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histological confirmation of cancer (any cancer type, any stage) * Age ≥ 18 years old * Received an integrated supportive care need assessment. * Sign the consent form for the PROACT study. Exclusion Criteria: * Absence or inability of written consent from the patient. * Does not understand or speak French.
Where this trial is running
Villejuif
- Gustave Roussy — Villejuif, France (RECRUITING)
Study contacts
- Principal investigator: Ines VAZ LUIS — Gustave Roussy, Cancer Campus, Grand Paris
- Study coordinator: Maria Alice BORINELLI-FRANZOI
- Email: Mariaalice.BORINELLI-FRANZOI@gustaveroussy.fr
- Phone: +33 (0)1 42 11 42 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Any Cancer, supportive care pathway, cancer, master protocol, supportive care, Distress